Regulatory updates in China are incorporated into drug quality audits through continuous monitoring of national guidelines, integrating changes into audit protocols, and training auditors on new requirements. Companies ensure compliance by updating standard operating procedures and conducting regular internal reviews to align with the latest regulatory standards and expectations.